Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02803242 · ClinicalTrials.gov registry record
COPD Patient-Powered Research Network
A clinical trial of Emphysema and Chronic Bronchitis, sponsored by COPD Foundation.
- Recruiting
- Registry status
- 75,000
- Enrollment target
- 1
- Study location
NCT02803242: Recruiting study of Emphysema and Chronic Bronchitis, sponsored by COPD Foundation.
NCT02803242 is a study of Emphysema and Chronic Bronchitis that is actively recruiting participants, run by COPD Foundation. The registered enrollment target is 75,000 participants, above the 803-participant average among 25 other Emphysema trials with a reported enrollment target (9240% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02803242, a study of Emphysema and Chronic Bronchitis, is actively recruiting participants, sponsored by COPD Foundation.
- RECRUITING
- Registry status
- 75,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The COPD Patient-Powered Research Network (COPD PPRN) is a patient research registry with the goal of enrolling 75,000 or more COPD patients and those at risk who are willing to share their heath information over several years and participate in research. The COPD PPRN has built an online platform to allow volunteers to enroll electronically, complete surveys, be contacted about studies they qualify for and become connected to COPD resources. The goal of the registry is to speed research to find better treatments for COPD and ultimately a cure.
Conditions Studied
Interventions
- OTHER Patient Reported Outcomes
Study Locations (1)
District of Columbia
- COPD Foundation - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75,000 participants |
| Start Date | 2014-08 |
| Est. Completion | 2030-01 |
What NCT02803242 shows while recruiting
NCT02803242 is an observational study that tracks outcomes without assigning an intervention. Its 75,000 participants enrollment target places it among the larger protocols in the corpus, above the 803-participant average among 25 other Emphysema trials with a reported enrollment target (9240% higher).
The record links to 4 conditions, with Emphysema appearing as the primary indexed condition, and to 1 intervention - of which Patient Reported Outcomes is the first listed.
NCT02803242 reports a single indexed study location in District of Columbia.
Frequently Asked Questions
What is clinical trial NCT02803242 about?
NCT02803242 is a clinical study titled "COPD Patient-Powered Research Network". The COPD Patient-Powered Research Network (COPD PPRN) is a patient research registry with the goal of enrolling 75,000 or more COPD patients and those at risk who are willing to share their heath information over several years and participate in research. The COPD PPRN has built an online platform t...
What is the current status of trial NCT02803242?
This trial is currently recruiting. The enrollment target is 75,000 participants. The study started on 2014-08. Estimated completion is 2030-01.
What conditions does trial NCT02803242 study?
This clinical trial studies the following conditions: Emphysema, Chronic Bronchitis, Chronic Obstructive Pulmonary Disorder, Chronic Obstructive Lung Disease.
What interventions are being tested in trial NCT02803242?
The interventions under investigation include: Patient Reported Outcomes (OTHER).
Who is sponsoring clinical trial NCT02803242?
This trial is sponsored by COPD Foundation, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02803242 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Emphysema
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02803242's enrollment target sits among peer trials
75,000 1st of 25 higher than 25 of 25 other Emphysema trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Emphysema trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Site and Mechanism(s) of Expiratory Airflow Limitation in COPD, Emphysema and Asthma-COPD Overlap
RECRUITING
-
Long-term, Open-label Study of SAR447537 (INBRX-101) in Adults With Alpha-1 Antitrypsin Deficiency Emphysema
RECRUITING · Phase 2
-
Biological Effects of Quercetin in COPD Phase II
RECRUITING · Phase 2
-
Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
RECRUITING · NA
-
Implementation of a Sarcopenia Clinic to Diagnose and Treat Skeletal Muscle Loss Due to COPD
RECRUITING · NA
-
STRIVE Post-Market Registry Study
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02402244 · 75,000 participants
Project: Every Child for Younger Patients With Cancer
- NCT04611568 · 75,000 participants · NA
War on Melanoma™ Public Health & Education Campaign
- NCT00063063 · 80,000 participants
Generic Database of Very Low Birth Weight Infants
- NCT06625983 · 80,000 participants · NA
Use of a Colorectal Cancer Screening Decision Support Tool in Primary Care
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia